Clinical Studies
临床研究
基本信息
- 批准号:7288639
- 负责人:
- 金额:$ 21.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse eventAdvisory CommitteesBasic ScienceBiological ProcessBloodBronchial LavagesBronchoalveolar LavageBudgetsCellsChloride IonChloridesClinicalClinical ResearchClinical TrialsCollectionContractsCystic FibrosisDEXADataDatabasesDevelopmentDiffusionDocumentationEpithelialEpithelial CellsExercise stress testExhalationFecesGasesHusbandImaging TechniquesIndustryInfantInvestigationIron binding capacity measurementIrrigationLiquid substanceMeasurementMetabolicNasal Lavage FluidNitric OxideNoseOscillometryOutcome MeasurePatient SelectionPatientsPlasmaPlethysmographyPopulationPopulation ResearchPreparationProceduresProcessProtocols documentationPulmonary function testsPurposeQuality ControlRadiology SpecialtyRecruitment ActivityReportingResearch Ethics CommitteesResearch PersonnelResourcesRetrospective StudiesSamplingScheduleScientistServicesSourceSpecimenSpirometrySputumStandards of Weights and MeasuresSweat testTestingThoracic RadiographyTissue BanksTissuesTranslationsUnited States Food and Drug AdministrationUrineWalkingbench to bedsidedesignperformance testsresearch study
项目摘要
The Clinical Studies Core is designed to 1) Assist investigators in accessing, selecting, and recruiting cystic
fibrosis and control patients for clinical trials, and to husband the patient resources of the Center. 2) Assist
investigators in the planning and execution of clinical trials, 3) Provide oversight and/or performance of
tests and procedures, including quality control. 4) Provide oversight of collection and processing of biologic
specimens, including BAL fluid and cell samples, nasal lavage fluid/cells and nasal epithelial cells from
scrapping, sputum (induced and expectorated), exhaled breath condensate, blood, urine, and stool. 5)
Maintain a specimen and tissue bank of samples collected from current and former patients 6) Maintain the
database for all patients ever seen at the Cleveland CF Center since its inception (1558 total patients; 360
active patients) for purposes of patient selection for clinical trials and studies, retrospective clinical studies,
and cooperation with various national databases. 7) Facilitate the translation of discoveries made by basic
science investigators into clinical investigation where applicable, including the development of outcome
measures appropriate for specific studies; and to engage basic scientists to investigate questions identified
in clinical practice or clinical studies. This Core makes available our well-characterized patient population
for clinical studies, and facilitates the bench to bedside translation of ideas from our basic science labs. The
Core-supported clinical projects also generate hypotheses that are in turn returned to basic science labs for
more detailed investigation. This is an integral component of the Translational Center.
临床研究核心旨在1)协助研究者访问、选择和招募囊性
纤维化和对照患者进行临床试验,并节约中心的患者资源。2)协助
研究者参与临床试验的规划和执行,3)监督和/或执行
测试和程序,包括质量控制。4)监督生物制品的收集和处理
样本,包括BAL液和细胞样本、鼻灌洗液/细胞和鼻上皮细胞,
刮痧、痰(诱导和咳出)、呼出气冷凝液、血液、尿液和粪便。第五章)
维护从当前和以前的患者中收集的样本的标本和组织库6)维护
克利夫兰CF中心自成立以来所有患者的数据库(共1558名患者; 360名
活跃患者),用于临床试验和研究的患者选择,回顾性临床研究,
与各国数据库的合作。7)促进基础科学发现的翻译
科学研究者参与临床研究(如适用),包括结局的制定
采取适合具体研究的措施;并请基础科学家调查所确定的问题
在临床实践或临床研究中。该核心使我们的特征良好的患者人群可用
用于临床研究,并促进了从我们的基础科学实验室的想法到床边的翻译。的
核心支持的临床项目还产生假设,这些假设又被送回基础科学实验室,
更详细的调查。这是翻译中心的一个组成部分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL W. KONSTAN其他文献
MICHAEL W. KONSTAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL W. KONSTAN', 18)}}的其他基金
Clinical and Translational Science Collaborative of Cleveland
克利夫兰临床与转化科学合作组织
- 批准号:
9978966 - 财政年份:2018
- 资助金额:
$ 21.42万 - 项目类别:
Clinical and Translational Science Collaborative of Cleveland
克利夫兰临床与转化科学合作组织
- 批准号:
9093875 - 财政年份:2007
- 资助金额:
$ 21.42万 - 项目类别:
Clinical and Translational Science Collaborative of Cleveland
克利夫兰临床与转化科学合作组织
- 批准号:
9093876 - 财政年份:2007
- 资助金额:
$ 21.42万 - 项目类别:
PTC124 AS AN ORAL TREATMENT FOR NONSENSE-MUTATION-MEDIATED CYSTIC FIBROSIS
PTC124 作为无义突变介导的囊性纤维化的口服治疗药物
- 批准号:
7378077 - 财政年份:2006
- 资助金额:
$ 21.42万 - 项目类别:
BIIL284BS IN ADULT AND PEDIATRIC CYSTIC FIBROSIS PATIENTS
BIIL284BS 在成人和儿童囊性纤维化患者中的应用
- 批准号:
7202776 - 财政年份:2005
- 资助金额:
$ 21.42万 - 项目类别:
ORAL THERACLEC-TOTAL IN CF PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY
胰腺外分泌功能不全的 CF 患者口服 THERACLEC-TOTAL
- 批准号:
7202793 - 财政年份:2005
- 资助金额:
$ 21.42万 - 项目类别:
TOBRAMYCIN FOR INHALATION (TOBI) IN YOUNG CHILDREN WITH CYSTIC FIBROSIS
患有囊性纤维化的幼儿吸入用妥布霉素 (Tobi)
- 批准号:
7202765 - 财政年份:2005
- 资助金额:
$ 21.42万 - 项目类别:
BIIL284BS in adult and pediatric cystic fibrosis patients
成人和儿童囊性纤维化患者中的 BIIL284BS
- 批准号:
6974994 - 财政年份:2004
- 资助金额:
$ 21.42万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 21.42万 - 项目类别:
Standard Grant